期刊文献+

血栓抽吸治疗急性ST抬高型心肌梗死神经内分泌变化的临床研究 被引量:2

Study on neuroendocrine change in patients with ST segment elevation in acute myocardial infarction using thrombectomy
下载PDF
导出
摘要 目的探讨应用血栓抽吸装置GuardWire PlusTM行血栓抽吸治疗急性ST抬高型心肌梗死(STEMI)神经内分泌变化及其临床价值。方法将2004年9月至2006年9月在我院行急诊PCI的72例急性STEMI患者分为两组,A组(38例):血栓抽吸后支架植入组;B组(34例):直接PCI组。于手术当天、术后第1、2、3、5日分别测定外周血中内皮素(ET)、血浆肾素活性(PRA)、醛固酮(ALD)、血管紧张素Ⅱ(AngⅡ)、去甲肾上腺素(NE)、肾上腺素(E)水平。术后1周与3个月测定左室射血分数(LVEF),评价心功能。结果两组病例均成功地置入支架,术前两组患者的神经内分泌因子水平无显著差异(P>0.05),ET、PRA、AngII、ALD、E等神经内分泌因子于术后第1、2日A组下降较B组明显(P<0.05),两组间NE下降无明显差异(P>0.05)。术后3个月A组的LVEF明显高于B组(P<0.05)。结论血栓抽吸治疗急性STEMI较直接PCI能够明显改善恶化的神经内分泌变化,对心功能可能有潜在的保护作用。 Objective To study neuroendocrine change and clinical value of percutaneous thrombectomy system (GuardWire Plus^TM)in treatment of patients with ST-elevation acute myocardial infarction (STEMI). Methods 72 patients with STEMI underwent percutaneous coronary intervention(PCI)were divided into A group (38 patients)with direct stent placement after thrombectomy and B group (34 patients) with prim,ry PCI. The plasma levels of ET, PRA, ALD, Ang Ⅱ , NE, E were measured on the day of operation and the first, second, third and fifth days after PCI. Left ventricular ejection fraction(LVEF) was measured by echocardiography at one week and three months after PCI. Results The stents were successfully implanted in two groups. All the neuroendocrine factors have no difference between the two groups before operation. The first and second day after PCI, the levels of ET, PRA, ALD, Ang Ⅱ and E were significantly lower in A gronp than those in B group (P 〈 0.05). NE showed no difference after PCI (P 〉 0.05). Conclusions Deteriorated neuroendocrine changes are significantly improved with thrombectomy, providing potential benefits on heart function. (J Intervent Radiol, 2007, 16: 443-445 )
出处 《介入放射学杂志》 CSCD 2007年第7期443-445,共3页 Journal of Interventional Radiology
关键词 血栓抽吸 心肌梗死 神经内分泌 Thrombectomy Myocardial infarction Neuroendocrine
  • 相关文献

参考文献7

  • 1Gibbons RJ,Abrams J,Chstterjee K,et al.ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-summary article.A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines[J].Circulation,2003,107:149-158.
  • 2Task Force for the Diagnosis and Treatment of Chronic Heart Failure,European Society of Cardiology,Guidelines for the diagnosis and treatment of chronic heart failure[J].Eur Heart J,2001,22:1527-1560.
  • 3Antman EM,Anbe DT,Armstrong PW,et al.ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary.A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines[J].J Am coll Cardiol,2004,44:671-719.
  • 4Beltrame JF,Limaye SB,Wuttke I,et al.Coronary hemodynamic and metabolic studies of the coronary slow flow phenomenon[J].Am Heart J,2003,146:84-90.
  • 5Topol EJ,Yadav JS.Recoginition of the importance of embolization in atherosclerotic vascular disease[J].Circulation,2000,101:570-580.
  • 6Orrego PS,Delgado A,Piccalo G,et al.Distal protection in native coronary arteries during primary angioplasty in acute myocardial infarction:single-center experience[J].Catheter Cardiovasc Interv,2003,60:152-158.
  • 7Li SS,Lam CW,So YC,et al.The use of a distal occlusion balloon protection device in acute coronary syndrome[J].Int Cardiol,2003,92:281 -284.

同被引文献19

  • 1陈步星,马凤云,罗维,阮剑洪,谢文丽,赵希哲,孙淑红,王枫,郭旭梅,褚晓雯.光学相干断层成像评价冠状动脉内支架术后即刻支架周围组织结构改变[J].中国循环杂志,2007,22(4):271-274. 被引量:9
  • 2中华医学会心血管病学分会,中华心血管病杂志编辑委员会.急性ST段抬高型心肌梗死诊断和治疗指南.中华心血管病杂志,2010,38:675-690.
  • 3Heusch G, Kleinbongard P, Bse D, et al. Coronary microem- bolization: from bedside to bench and back to bedside. Circula- tion, 2009,120 : 1822-1836.
  • 4Niecoli G, Burzotta F, Galiuto L, et al. Myocardial no-reflow in humans. J Am Coil Cardiol, 2009,54 : 281-292.
  • 5Van't Hof AW, Liem A, Suryapranata H, et al. Angiographic as- sessment of myocardial reperfusion in patients treated with prima- ry angioplasty for acute myocardial infarction: Myocardial blush grade. Zwolle Myocardial Infarction Study Group. Circulation, 1998,97 : 2302-2306.
  • 6Ari H, Ozkan H, Karacinar A, et al. The Effect of high-dose Clopidogrel treatment in patients with elopidogrel resistance (The EFFICIENT Trial). Int J Cardiol, 2012,157 : 374-380.
  • 7Levine GN, Bates ER, Blankenship JC. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A Report of the American College of Cardiology Foundation/American Heart Association. Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Journal of the American College of Cardiology, 2011,58 : e44-122.
  • 8Wang YS, Wu BT, Shu XH, et al. Meta-analysisof randomized controlled trials comparing intracoronary and intravenous administration of glycoprotein H b/: a inhibitors in patients with ST-elevation myocardial infarction. Am J Cardiol,2012,109: 1124-1130.
  • 9Prati F, Capodanno D, Pawlowski T, et al. Local delivery ver- sus intracoronary infusion of abciximab in patients with acutecoronary syndromes. JACC: Cardiovasc Interv,2010,3:928- 934.
  • 10Stone GW, Maehara A, Witzenbichler B, et al. Intracoronary ab- ciximab and aspiration thrombectomy in patients with large an- terior myocardial infarction: the INFUSE-AMI randomized trial. JAMA, 2012,307 : 1817-1826.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部